For: | Zhou CQ, Liu S, Xue LY, Wang YH, Zhu HX, Lu N, Xu NZ. Down-regulation of γ-synuclein in human esophageal squamous cell carcinoma. World J Gastroenterol 2003; 9(9): 1900-1903 [PMID: 12970872 DOI: 10.3748/wjg.v9.i9.1900] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v9/i9/1900.htm |
Number | Citing Articles |
1 |
Jingsong He, Ni Xie, Jianbo Yang, Hong Guan, Weicai Chen, Huisheng Wu, Zishan Yuan, Kun Wang, Guojin Li, Jie Sun, Limin Yu. siRNA-Mediated Suppression of Synuclein γ Inhibits MDA-MB-231 Cell Migration and Proliferation by Downregulating the Phosphorylation of AKT and ERK. Journal of Breast Cancer 2014; 17(3): 200 doi: 10.4048/jbc.2014.17.3.200
|
2 |
Vinay K Singh, Zongchao Jia. Targeting synuclein-γ to counteract drug resistance in cancer. Expert Opinion on Therapeutic Targets 2008; 12(1): 59 doi: 10.1517/14728222.12.1.59
|
3 |
BO LIANG, XIN-JUN WANG, PEI-HONG SHEN, XUE-YUAN LI, HONG-WEI CHENG, QIAO SHAN, KUI-YUAN GUO, YU-WEN CAO, QING-XIA FAN, RUI-FENG ZHENG, BEI LI, WEI ZHANG, YAN-WEI LI, KAI YANG. Synuclein-γ suppression mediated by RNA interference inhibits the clonogenicity and invasiveness of MCF-7 cells. Oncology Letters 2013; 5(4): 1347 doi: 10.3892/ol.2013.1192
|
4 |
Mushfika Ahmad, Samir Attoub, Maneesh N. Singh, Francis L. Martin, Omar M. A. El‐Agnaf. γ‐Synuclein and the progression of cancer. The FASEB Journal 2007; 21(13): 3419 doi: 10.1096/fj.07-8379rev
|
5 |
Shangbin Yang, Shun He, Xiaobo Zhou, Mei Liu, Hongxia Zhu, Yihua Wang, Wei Zhang, Shuang Yan, Lanping Quan, Jingfeng Bai, Ningzhi Xu. Suppression of Aurora-A oncogenic potential by c-Myc downregulation. Experimental and Molecular Medicine 2010; 42(11): 759 doi: 10.3858/emm.2010.42.11.077
|
6 |
Qihang Yan, Li Liu, Han Yang, Chendi Xu, Zhen Wang, Qi Wang, Zixiang Wu, Chuanqiang Wu, Lingjun Dong, Junye Wang, Ming Wu. Long Non-Coding RNA OIP5-AS1 Inhibits the Proliferation and Migration of Esophageal Squamous Carcinoma Cells by Targeting FOXD1/miR-30a-5p Axis and the Effect of Micro- and Nano-Particles on Targeting Transfection System. Journal of Biomedical Nanotechnology 2021; 17(7): 1380 doi: 10.1166/jbn.2021.3114
|
7 |
Aiping Lu, Qing Li, Jingwen Liu. Regulatory mechanisms for abnormal expression of the human breast cancer specific gene 1 in breast cancer cells. Science in China Series C: Life Sciences 2006; 49(4): 403 doi: 10.1007/s11427-006-2006-1
|
8 |
Didem Tastekin, Suleyman Kargin, Mehmet Karabulut, Naile Yaldız, Makbule Tambas, Necla Gurdal, Ali Murat Tatli, Deniz Arslan, Ali Fuat Kaan Gok, Faruk Aykan. Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients. Tumor Biology 2014; 35(12): 11871 doi: 10.1007/s13277-014-2429-4
|
9 |
Lucía C. Zanotti, Florencia Malizia, Nahuel Cesatti Laluce, Aylén Avila, Macarena Mamberto, Luciano E. Anselmino, Mauricio Menacho-Márquez. Synuclein Proteins in Cancer Development and Progression. Biomolecules 2023; 13(6): 980 doi: 10.3390/biom13060980
|
10 |
Kai-Wey Goh, Yee-How Say. γ-Synuclein confers both pro-invasive and doxorubicin-mediated pro-apoptotic properties to the colon adenocarcinoma LS 174T cell line. Tumor Biology 2015; 36(10): 7947 doi: 10.1007/s13277-015-3455-6
|
11 |
Junyi Chen, Li Jiao, Chuanliang Xu, Yongwei Yu, Zhensheng Zhang, Zheng Chang, Zhen Deng, Yinghao Sun. Neural protein gamma-synuclein interacting with androgen receptor promotes human prostate cancer progression. BMC Cancer 2012; 12(1) doi: 10.1186/1471-2407-12-593
|
12 |
J.C. Cheng, M.T. Chiang, C.H. Lee, S.Y. Liu, K.C. Chiu, Y.T. Chou, R.Y. Huang, S.M. Huang, Y.S. Shieh. γ-Synuclein Expression Is a Malignant Index in Oral Squamous Cell Carcinoma. Journal of Dental Research 2016; 95(4): 439 doi: 10.1177/0022034515621728
|
13 |
Yi-hua Wang, Shuang Liu, Guo Zhang, Cui-qi Zhou, Hong-xia Zhu, Xiao-bo Zhou, Lan-ping Quan, Jin-feng Bai, Ning-zhi Xu. Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo
. Breast Cancer Research 2004; 7(2) doi: 10.1186/bcr975
|
14 |
QING YE, FENG HUANG, XIAO-YING WANG, YANG-MEI XU, FU-SHENG GONG, LI-JIE HUANG, CHUN-KANG YANG, QIU-HONG ZHENG, MIN-GANG YING. Effects of γ-synuclein on the tumorigenicity and metastasis of colon cancer SW1116 cells in vitro and in vivo. Oncology Reports 2013; 30(5): 2161 doi: 10.3892/or.2013.2688
|
15 |
Qing Ye, Bo Feng, Yuan-Fei Peng, Xue-Hua Chen, Qu Cai, Bei-Qin Yu, Liang-Hui Li, Ming-Yuan Qiu, Bing-Ya Liu, Min-Hua Zheng. Expression of γ-synuclein in colorectal cancer tissues and its role on colorectal cancer cell line HCT116. World Journal of Gastroenterology 2009; 15(40): 5035-5043 doi: 10.3748/wjg.15.5035
|
16 |
Jin-Song He, Ni Xie, Jian-Bo Yang, Hong Guan, Wei-Cai Chen, Chang Zou, Yi-Wen Ouyang, You-Sheng Mao, Xue-Ying Luo, Yue Pan, Li Fu. BCSG1 siRNA delivered by lentiviral vector suppressed proliferation and migration of MDA-MB-231 cells. International Journal of Molecular Medicine 2017; doi: 10.3892/ijmm.2017.3355
|
17 |
Qing Ye, Min‐Hua Zheng, Qu Cai, Bo Feng, Xue‐Hua Chen, Bei‐Qin Yu, Ya‐Bo Gao, Jun Ji, Ai‐Guo Lu, Jian‐Wen Li, Ming‐Liang Wang, Bing‐Ya Liu. Aberrant expression and demethylation of γ‐synuclein in colorectal cancer, correlated with progression of the disease. Cancer Science 2008; 99(10): 1924 doi: 10.1111/j.1349-7006.2008.00947.x
|
18 |
Jing Zou, Yujuan J Fan, Yaqing Q Meng, Hong Xu, Jiangtao Fan. An exploratory analysis of γ-synuclein expression in endometrioid endometrial cancer. BMJ Open 2012; 2(2): e000611 doi: 10.1136/bmjopen-2011-000611
|